Getting Lantus Dosing Right: A Step-by-Step Walkthrough

Lantus at a glance:

• Drug class: Long-acting basal insulin analog
• Manufacturer: Sanofi
• FDA approved: 2000
• Route: subcutaneous injection (SoloStar pen or vial)
• Typical frequency: once daily, same time each day
• Half-life: ~12 hours (effective duration ~24 hours)
• Cash price (US): ~$280–$340/month list; $35/month cap for Medicare beneficiaries; biosimilar (Semglee) available at lower cost

Here's the core rule for Lantus dosing: titrate slowly, hold each step long enough, and don't try to outpace your body. Starting dose for insulin-naive T2D is typically 0.

Standard Dosing Schedule for Lantus

Starting dose for insulin-naive T2D is typically 0.2 U/kg/day or 10 U/day, titrated by fasting glucose. T1D doses are individualized.

The typical schedule for Lantus is once daily, same time each day via subcutaneous injection (SoloStar pen or vial). Half-life of ~12 hours (effective duration ~24 hours) explains why this schedule works — the drug stays active long enough to support that interval.

Titration: Why Starting Low Matters

For this class of compound, gradual titration is the standard approach. The starting doses listed above are not therapeutic — they exist to let the body adapt and to reduce gastrointestinal symptoms .

A typical titration plan for Lantus holds each dose step for at least four weeks before moving up. Faster titration is associated with more dropouts due to side effects.

Missed Doses

If a dose of Lantus is missed: for daily schedules, the rule of thumb is to take it as soon as remembered if within a defined window, otherwise skip it and resume the regular schedule. The exact window depends on the half-life (~12 hours (effective duration ~24 hours)) and the specific product label. Never double up to make up for a missed dose.

Dose Adjustments

Dose adjustments may be needed for the following:

• Significant weight loss or weight gain
• Side-effect intolerance at the current step
• Changes in renal or hepatic function
• Drug interactions (particularly relevant for insulin)

We cover the side-effect side of dose decisions in Lantus side effects and the cost angle of dose escalation in Lantus cost.

What the Trials Used

Published trial data for Lantus comes primarily from: Riddle MC et al., Treat-to-Target Trial (Diabetes Care, 2003) — established titration framework now used clinically.

That data drives the labeled dosing range, which is what physicians prescribe by.

Special Populations

The dosing guidance above applies to general adult use. Special populations — pregnancy, pediatric, severe renal impairment, hepatic dysfunction, elderly with frailty — require individualized assessment that this page can't substitute for.

For Lantus: the hypoglycemia apply.

Bottom Line

Lantus dosing isn't intuitive but it isn't complicated either. Follow the schedule, talk to your prescriber when something feels off, and don't make changes on your own.

Frequently Asked Questions

Related Reading

• Is Lantus Right for You? An Evidence-Based Breakdown
• What Nobody Tells You About Lantus Side Effects
• Lantus Outcomes Decoded: Who Responds Best and Why
• How Much Does Lantus Really Cost? The Honest Breakdown
• What Is Humalog? Everything You Should Know Before Starting
• Lantus Dosing Patterns in the Research Literature

Sources

• Heise T et al. Insulin Pharmacokinetics and Pharmacodynamics. Diabetes Obes Metab 2017;19:3.
• American Diabetes Association. Standards of Care in Diabetes — 2024. Diabetes Care 2024;47(Suppl 1).

This page is informational only and is not medical advice. Always follow your prescribing clinician's dosing instructions.